New York State Common Retirement Fund Madrigal Pharmaceuticals, Inc. Transaction History
New York State Common Retirement Fund
- $74.9 Billion
- Q3 2025
A detailed history of New York State Common Retirement Fund transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 69,273 shares of MDGL stock, worth $36.7 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
69,273
Previous 61,062
13.45%
Holding current value
$36.7 Million
Previous $18.5 Million
71.94%
% of portfolio
0.04%
Previous 0.03%
Shares
38 transactions
Others Institutions Holding MDGL
# of Institutions
407Shares Held
23.1MCall Options Held
665KPut Options Held
514K-
Baker Bros. Advisors LP New York, NY2.14MShares$1.13 Billion8.0% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$1.06 Billion12.22% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny1.91MShares$1.01 Billion31.28% of portfolio
-
Janus Henderson Group PLC London, X01.84MShares$975 Million0.41% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.83MShares$970 Million11.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $9.05B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...